We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema.
- Authors
Weatherhead, S C; Wahie, S; Reynolds, N J; Meggitt, S J
- Abstract
Treatment options for moderate-to-severe atopic eczema are limited. Although methotrexate (MTX) is a widely used and effective treatment for psoriasis, there have been no previous prospective trials of its use in refractory atopic eczema, despite a few small, retrospective reports suggesting that it is a well-tolerated and effective treatment.
- Publication
The British journal of dermatology, 2007, Vol 156, Issue 2, p346
- ISSN
0007-0963
- Publication type
Journal Article
- DOI
10.1111/j.1365-2133.2006.07686.x